Athanasios D Anastasilakis, MD, PhD
424 General Military Hospital, Thessaloniki, Greece · 424 Gen. Military Hospital Thessaloniki, Greece · 424 General Military Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Athanasios D Anastasilakis, MD, PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:49 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT05493761 · Effect of Anti-osteoporotic Medications on Nonalcoholic Fatty Liver DiseaseAristotle University Of Thessaloniki · completed · Nonalcoholic Fatty Liver, Osteoporosis, Postmenopausal · study director
- N/ANCT04338529 · Alendronate in an Weekly Effervescent Tablet Formulation Following Denosumab Discontinuation251 Hellenic Air Force & VA General Hospital · completed · Postmenopausal Osteoporosis · study director
- N/ANCT01986530 · Circulating Levels of Irisin in Healthy Young Subjects424 General Military Hospital · completed · Healthy Subjects · principal investigator
- N/ANCT01572545 · Comparative Effect of Zoledronic Acid Versus Denosumab on Serum Sclerostin of Postmenopausal Women With Low Bone MassAristotle University Of Thessaloniki · completed · Postmenopausal Osteoporosis · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:49 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.